Impact of COVID-19 on heart health for people with chronic conditions in NYC
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
This study looks at how the COVID-19 pandemic changed healthcare services and impacted heart health for people in New York City who have multiple health issues, especially those who are more vulnerable, to understand the long-term effects and find ways to improve care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10914048 on NIH RePORTER |
What this research studies
This research investigates how the COVID-19 pandemic disrupted healthcare services and affected cardiovascular health among individuals with multiple chronic conditions in New York City. It focuses on understanding the long-term consequences of these disruptions, particularly for vulnerable populations. The study utilizes existing electronic health records from multiple academic medical centers to analyze health outcomes and disparities. By examining the adoption of telemedicine and modified care during the pandemic, the research aims to identify factors that may have worsened health inequalities.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals over 21 years old with multiple chronic conditions such as diabetes, hypertension, or obesity.
Not a fit: Patients without chronic conditions or those not affected by healthcare disruptions during the COVID-19 pandemic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare strategies that better support patients with chronic conditions during future health crises.
How similar studies have performed: Other research has shown that healthcare disruptions during crises can significantly impact patient outcomes, indicating that this study builds on established findings.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Dodson, John a — New York University School of Medicine
- Study coordinator: Dodson, John a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.